Published in Surgery Litigation and Law Weekly, April 6th, 2007
The European Commission has reclassified these joint replacement implants following an initial request from the UK's Medicines and Healthcare products Regulatory Agency (MHRA). For several years, the MHRA has been concerned about the performance of hip implants, which can lead to premature implant failure and early revision and replacement of the artificial joint.
Joint replacements have been reclassified from class IIb (medium risk) to class III (high risk)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly